levofloxacin has been researched along with oxytetracycline, anhydrous in 8 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (oxytetracycline, anhydrous) | Trials (oxytetracycline, anhydrous) | Recent Studies (post-2010) (oxytetracycline, anhydrous) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 6,721 | 267 | 976 |
Protein | Taxonomy | levofloxacin (IC50) | oxytetracycline, anhydrous (IC50) |
---|---|---|---|
microphthalmia-associated transcription factor isoform 9 | Homo sapiens (human) | 1.7087 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Feng, L; Li, Y; Lu, T; Qian, H; Zhang, J; Zhang, Z; Zhou, Z | 1 |
Ahmed, I; Arshad, M; Farooq, MA; Fiaz, M; Hassan, SMU; Khokhar, MF; Niazi, AK | 1 |
Amelot, M; Bougeard, S; Jouy, E; Keita, A; Kempf, I; Laurentie, J; Mourand, G; Serror, P | 1 |
1 review(s) available for levofloxacin and oxytetracycline, anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for levofloxacin and oxytetracycline, anhydrous
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Adverse effects of levofloxacin and oxytetracycline on aquatic microbial communities.
Topics: Anti-Bacterial Agents; Levofloxacin; Manure; Microbiota; Oxytetracycline | 2020 |
Antibiotics induced changes in nitrogen metabolism and antioxidative enzymes in mung bean (Vigna radiata).
Topics: Anti-Bacterial Agents; Antioxidants; Fabaceae; Glutamate-Ammonia Ligase; Levofloxacin; Oxytetracycline; Soil; Vigna | 2023 |
Study of the effect of administration of narasin or antibiotics on in vivo selection of a narasin- and multidrug-resistant Enterococcus cecorum strain.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chickens; Levofloxacin; Oxytetracycline; Vancomycin | 2023 |